These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20607802)
1. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells. Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A; Shi R; Glass J; Mathis JM; Williams BJ; Meyers S J Cell Physiol; 2010 Nov; 225(3):875-87. PubMed ID: 20607802 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer]. Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874 [TBL] [Abstract][Full Text] [Related]
5. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
6. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells. Liu H; Chen A; Guo F; Yuan L Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476 [TBL] [Abstract][Full Text] [Related]
7. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958 [TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479 [TBL] [Abstract][Full Text] [Related]
9. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Kitoh A; Ono M; Naoe Y; Ohkura N; Yamaguchi T; Yaguchi H; Kitabayashi I; Tsukada T; Nomura T; Miyachi Y; Taniuchi I; Sakaguchi S Immunity; 2009 Oct; 31(4):609-20. PubMed ID: 19800266 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Gao AC; Lou W; Isaacs JT Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237 [TBL] [Abstract][Full Text] [Related]
12. Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1. Bollerot K; Romero S; Dunon D; Jaffredo T Gene Expr Patterns; 2005 Dec; 6(1):29-39. PubMed ID: 16033710 [TBL] [Abstract][Full Text] [Related]
13. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101 [TBL] [Abstract][Full Text] [Related]
14. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818 [TBL] [Abstract][Full Text] [Related]
15. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334 [TBL] [Abstract][Full Text] [Related]
16. Tumor promoting properties of the ETS protein MEF in ovarian cancer. Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815 [TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
18. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460 [TBL] [Abstract][Full Text] [Related]
20. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]